Home  |  About SITC  |   Twitter  |  LinkedIn  |  YouTube  |  Oncology Tube  |  Sitemap

Workshop on Monoclonal Antibodies in Cancer

Workshop Main Page  |  Highlights  |  Program Purpose  |  Presentations Slides & Schedule | Faculty
Preliminary Program  |  Photos

October 1, 2010
Hyatt Regency Washington on Capitol Hill
Washington, D.C.

Program Schedule
To view slides from a presenter click the icon next to the presentation title.

Friday, October 1, 2010 
8:00 am - 8:15 am Presentation SlidesWelcome & Overview: Monoclonal Antibodies in Cancer
George J. Weiner, MD - University of Iowa
8:15 am - 10:05 am Session 1: Tumor-Targeted Antibodies
Chair:  Ira Mellman, PhD - Genentech, Inc.

Targeting Activated HER2 in Solid Tumors
Mark X. Sliwkowski, PhD - Genentech, Inc. 

Presentation SlidesMonoclonal Antibody Immunotherapy
Louis M. Weiner, MD - Georgetown University Medical Center

Presentaton SlidesCombining Tumor-Reactive mAbs with Cytokines to Induce ADCC in Patients
Paul M. Sondel, MD, PhD - University of Wisconsin, Madison
10:30 am - 12:00 pm Session 2: Immunomodulatory Antibodies
Chair:  Glenn Dranoff, MD - Dana-Farber Cancer Institute

Immune Modulation by Antibody
Lieping Chen, MD, PhD - Johns Hopkins University School of Medicine

Immunomodulation with Antibodies Blocking the B7-H1/PD-1 Axis
Suzanne L. Topalian, MD - Johns Hopkins University School of Medicine
1:00 pm - 2:30 pm Session 3: Investigating Antibodies as "Vaccines"
Chair:  Ira Mellman, PhD - Genentech, Inc.

Antibody Therapeutics in Cancer: Converting Passive to Active
Raphael Clynes, MD, PhD - Colubmia University

Presentation SlidesAntibody-Targeted Vaccines
Tibor Keler, PhD - Celldex Therapeutics, Inc.
3:00 pm - 5:00 pm Session 4: Antibody Engineering
Chair:  George J. Weiner, MD - University of Iowa

Presentation SlidesTwo-in-One Antibody: From Proof-of-Concept to Therapeutic Candidate
Germaine Fuh - Genentech, Inc.

Presentation SlidesEngineered Anti-Cancer Antibodies with Enhanced Effector Functions
Pablo Umaña, PhD - Roche Glycart AG

Presentation SlidesT Cell-Engaging Antibodies for Cancer Therapy
Patrick A. Baeuerle, PhD - Micromet, Inc.
   
Saturday, October 2 - Monday, October 4, 2010
    iSBTc 25th Annual Meeting
For more information, please click here

  Creative Commons License
All presentations are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.



Society for Immunotherapy of Cancer
555 East Wells Street, Suite 1100  |  Milwaukee, WI 53202-3823 USA
Tel: +1 414 271 2456  |  Fax: +1 414 276 3349  |  Email: info@sitcancer.org
About SITC  |  Meetings  |  Membership  |  Patient/Consumer Resources  |  Professional Resources  |  Support SITC
© 2014 Society for Immunotherapy of Cancer. All rights reserved.